AB
AbbVie
ABBV · NYSE
$256.37 -1.48% (-$3.84)
1M +4.19%
Market Cap $459.9B
P/E Ratio 72.84x
Div. Yield 2.62%
ROE -
Bulios Fair Price
$168.69
34.2% downside
Trenutna cena
$256.37
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ABBV trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
9/9Valuation
21 /100
Expensive P/E 72.84x
EV/EBITDA 24.68x
P/FCF 23.37x
Growth
11 /100
Declining EPS growth 29.03%
Rev. growth 1.75%
FCF growth 9.76%
Profitability
93 /100
Strong Gross margin 71.48%
Net margin 9.81%
FCF margin 30.57%
Quality
60 /100
Average ROIC 13.46%
ROA 4.67%
Asset turnover 0.48x
Debt
41 /100
Moderate Current ratio 0.81x
Int. coverage 4.57x
Net debt/EBITDA 3.03x
Stability
70 /100
Stable Beta 0.28x
Rev. volatility 7.66%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ABBV
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert A. Michael
Employees
57,000
Headquarters
North Chicago
Prihajajoči dogodki
30 OKT.
Earnings
Upcoming earnings report